Your browser doesn't support javascript.
loading
COVID-19 in hematology: data from a hematologic and transplant unit.
Garnica, Marcia; Valetim, Marcia Rejane; Furtado, Paulo; Moreira, Maria Claudia; Bigni, Ricardo; Vinhas, Simone; Dias, Paulo Cesar; Fellows, Ilza; Martins, Wolney.
Afiliação
  • Garnica M; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil. Electronic address: marciagarnica@hucff.ufrj.br.
  • Valetim MR; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil.
  • Furtado P; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil.
  • Moreira MC; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil.
  • Bigni R; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil; Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil; América Oncologia, Rio de Janeiro, RJ, Brazil.
  • Vinhas S; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil.
  • Dias PC; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil.
  • Fellows I; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil.
  • Martins W; Complexo Hospitalar de Niterói (CHN), Niterói, RJ, Brazil; Universidade Federal Fluminense(UFF), Niterói, RJ, Brazil.
Hematol Transfus Cell Ther ; 42(4): 293-299, 2020.
Article em En | MEDLINE | ID: mdl-32929414
During the COVID-19 pandemic, special attention has been addressed in cancer care to mitigate the impact on the patient's prognosis. We addressed our preparation to face COVID-19 pandemic in a Hematological and Stem Cell Transplant Unit in Brazil during the first two months of COVID-19 pandemic and described COVID-19 cases in patients and health care workers (HCW). Modifications in daily routines included a separation of area and professionals, SARS-CoV-2 screening protocols, and others. A total of 47 patients and 54 HCW were tested for COVID-19, by PCR-SARS-CoV-2. We report 11 cases of COVID-19 in hematological patients (including 2 post stem cell transplant) and 28 cases in HCW. Hematological cases were most severe or moderate and presented with several poor risk factors. Among HCW, COVID-19 were mostly mild, and all recovered without hospitalization. A cluster was observed among HCW. Despite a decrease in the number of procedures, the Transplant Program performed 8 autologous and 4 allogeneic SCT during the period, and 49 onco-hematological patients were admitted to continuing their treatments. Although we observed a high frequency of COVID-19 among patients and HCW, showing that SARS-CoV-2 is disseminated in Brazil, hematological patients were safely treated during pandemic times.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2020 Tipo de documento: Article País de publicação: Brasil
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2020 Tipo de documento: Article País de publicação: Brasil